The risks of adverse events with venlafaxine and mirtazapine versus 'active placebo', placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis.
- DOI
- 10.1186/s13643-023-02221-5
- Published
- 2023 Mar 30
- Container
- Systematic reviews
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13643-023-02221-5,
title = {The risks of adverse events with venlafaxine and mirtazapine versus 'active placebo', placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis.},
author = {Jørgensen CK and Juul S and Siddiqui F and Horowitz MA and Moncrieff J and Munkholm K and Hengartner MP and Kirsch I and Gluud C and Jakobsen JC},
year = {2023},
journal = {Systematic reviews},
doi = {10.1186/s13643-023-02221-5},
url = {https://doi.org/10.1186/s13643-023-02221-5}
}RIS
TY - JOUR TI - The risks of adverse events with venlafaxine and mirtazapine versus 'active placebo', placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis. AU - Jørgensen CK AU - Juul S AU - Siddiqui F AU - Horowitz MA AU - Moncrieff J AU - Munkholm K AU - Hengartner MP AU - Kirsch I AU - Gluud C AU - Jakobsen JC PY - 2023 JO - Systematic reviews DO - 10.1186/s13643-023-02221-5 UR - https://doi.org/10.1186/s13643-023-02221-5 ER -
APA
CK, J., S, J., F, S., MA, H., J, M., K, M., MP, H., I, K., C, G., & JC, J. (2023). The risks of adverse events with venlafaxine and mirtazapine versus 'active placebo', placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis.. Systematic reviews. https://doi.org/10.1186/s13643-023-02221-5
Source records
- pubmed · retrieved 2026-09-26T06:08:48.347Z